GENE THERAPY RESOURCE PROGRAM (GTRP) Header
GENE THERAPY RESOURCE PROGRAM (GTRP) Header
HIGHLIGHTS
  
>Instructions for Submitting
   an RSA


>RSA Review Process
  
INFORMATION CENTER
>NHLBI Home

>FAQ's

>Regulatory Resources
  » Regulatory Guidelines
   » Fundamental Elements in
     Gene Vector Development

>National Gene Vector
  Biorepository

  » Article - April 2009 Download Adobe PDF Reader

>Publications and Presentations
  by GTRP Investigators


>NIH-RAID (Rapid Access to
  Interventional Development)

>Other Resources for Vector    Production
  » Association of Academic
      Biologics Manufacturers

Publications
Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo
White JD, Thesier DM, Swain JBD, Katz MG, Tomasulo C, Henderson A, Wang L, Yarnall C, Fargnoli A, Sumaroka M, Isidro A, Petrov M, Holt D, Nolen-Walston R, Koch WJ, Stedman HH, Rabinowitz J, Bridges CR
Gene Therapy (2011) 18; 546-552
The matricellular protein cysteine-rich protein 61 (CCN1/Cyr61) enhances physiological adaptation of retinal vessels and reduces pathological neovascularization associated with ischemic retinopathy
Hasan A, Pokeza N, Shaw L, Lee HS, Lazzaro D, Chintala H, Rosenbaum D, Grant MB, Chaqour B
Journal of Biological Chemistry. March 18, 2011;286(11):9542-9554
Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method
Chulay JD, Ye GJ, Thomas DL, Knop DR, Benson JM, Hutt JA, Wang G, Humphries M, Flotte TR
Human Gene Therapy. 2011 Feb;22:155-165
Gene therapy during cardiac surgery: role of surgical technique to minimize collateral organ gene expression
Katz MG, Swain JD, Fargnoli AS, Bridges CR
Interactive Cardiovascular and Thoracic Surgery. 2010 Dec;11(6):727-31
1 2 3
  
Presentations
Normalization of angiogenesis and vasculogenesis by CCN1: Implications in occular neovascular diseases
   Chaqour B
   The International CCN Society: Targets 2011, Vancouver, BC, Canada. 2011 September 24-27 (slides)
Transductional and transcriptional targeting of AAV to the pulmonary vasculature
   Passineau MJ, Zourelias L, Machen L, Benza RL
   American Thoracic Society 2011, Denver, Colorado. 2011 May 13-18 (poster)
Adeno-associated virus 9 vector in the gene therapy of occlusive vascular diseases
   Agrawal DK, Pankajakshan D, Del Core M, Pipinos I, Hatzoudis G
   European Atherosclerosis Society Congress 2010, Hamburg, Germany. 2010 June 20-23 (poster)
The next step from GWAS and eQTL candidate gene discovery: An in vivo follow up of novel genes identified through the Global Lipids Genetics Consortium
   Stylianou IM, Fitzgerald K, Kathiresan S, Rader DJ
   9th Annual Meeting of the Complex Trait Community, Chicago, Illinois. 2010 May 10 (slides)
1 2 3
  
  
For information about PDFs, click on the Accessibility Link below.